Evidence map›Paper›PMID 40837405›Full record

ArticleLeukemia research reports2025

Effective treatment of peritoneal myeloid sarcoma with decitabine and venetoclax: A case report.

Kavya Sudireddy, Minorvi Amin, Rafy Odeh, Patrick Svrcek, Salwa Khedr, Lloyd Hutchinson, Shyam A Patel, Jan Cerny, Laurie Pearson

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kavya SudireddyDepartment of Medicine, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Minorvi AminDepartment of Neurology, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Rafy OdehDepartment of Pathology, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Patrick SvrcekDepartment of Radiology, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Salwa KhedrDepartment of Pathology, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Lloyd HutchinsonDepartment of Pathology, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Shyam A PatelDivision of Hematology/Oncology, Department of Medicine, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Jan CernyDivision of Hematology/Oncology, Department of Medicine, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
Laurie PearsonDivision of Hematology/Oncology, Department of Medicine, UMass Chan Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloid sarcomas (MS) are rare extramedullary manifestations of myeloid progenitor cells occurring with or without acute myeloid leukemia. Peritoneal MS is exceptionally uncommon, with no established treatment guidelines, but treatment has historically consisted of cytotoxic chemotherapy. We present the case of a 78-year-old female with 60% CD34+, HLA-DR+, and CD33+ myeloblasts in ascitic fluid, while bone marrow biopsy demonstrated only molecular evidence of the leukemic clone with

Indexed as

Extramedullary AMLHypomethylating agentsPeritoneal myeloid sarcomaVenetoclax

Identifiers

PMID40837405
PMCPMC12363461

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.